Tesamorelin

Accelerating

Tesamorelin appears in 127 indexed publications going back to 2003, including 18 in the past twelve months. 23 registered trials appear on ClinicalTrials.gov.

127

Indexed publications

Past 12 months, against 4 the year before

Registered clinical trials

9,291

Monthly readers on Wikipedia, down 4%

Research Activity

Publication history

How much work has been indexed each year, from Europe PMC. Momentum is measured over a trailing twelve months rather than calendar years, so a partial current year never reads as a decline.

20152026

Publications per year. The final bar is the current year, still in progress.

Indexed publications per year
2015	5
2016	5
2017	5
2018	0
2019	4
2020	4
2021	8
2022	4
2023	3
2024	4
2025	5
2026	17

Public Attention

Who is looking it up

Monthly readers of the Tesamorelin article on English Wikipedia. An independent measure of curiosity, which often moves quite differently from the evidence.

2025-082026-07

Clinical Trials

The registered pipeline

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase distribution across the most recently updated registered trials.

Recruiting·Phase 2
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
Massachusetts General Hospital · estimated completion 2028-06-16
Terminated·Phase 4
Body Composition and Adipose Tissue in HIV
Columbia University · completed 2025-04-30
Recruiting·Phase 2
Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)
Hudson Biotech · estimated completion 2027-02-14
Completed·Phase 2
Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons
University of California, San Diego · completed 2023-10-15
Completed·Phase 2
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
Massachusetts General Hospital · completed 2024-07-10
Recruiting·Phase 2
Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
Johns Hopkins University · estimated completion 2027-12

References

Most recent work

The newest indexed records mentioning Tesamorelin, listed by publication date. Titles are shown as published and link to their source. Inclusion here is a record of what exists, not a judgement of what it shows.

2026-06-17·eNeurologicalSci
The effect of growth hormone-releasing hormone on cognition and brain connectivity in adults with cognition ranging from normal to mild cognitive impairment
Stewart CE, French KP, Wright TJ et al.
2026-07-08·BMJ open
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH): a clinical trial protocol
Erlandson KM, Gustafson L, Johnson JE et al.
2026-05-20·JBJS reviews
Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications
Villegas Meza AD, Nocek M, Mitchell BC et al.
2026-05-01·Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Differing Presentations of Excess Visceral Abdominal Fat in People Living With HIV: Two Clinical Cases Highlighting Distinct Therapeutic Pathways With Tesamorelin and Glucagon-Like Peptide-1 Receptor Agonists
Beach R, Tims-Cook Z, McGary CS et al.
2026-04-27·International journal of molecular sciences
Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives
Renke G, Chinellato L. et al.
2026-04-12·Sports medicine (Auckland, N.Z.)
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Mendias CL, Awan TM. et al.
2026-03-25·Pituitary
Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 study
Fleseriu M, Biller BMK, Webb SM et al.
2026-06-18·Frontiers in endocrinology
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
Dominikowski A, Rękoś Z, Olejarz M et al.

In the Catalogue

Tesamorelin available from Polaris Research

Tesamorelin 10mg

Growth & Sleep

$1.49View product

Supplied as research materials for laboratory use. Free express delivery Australia wide.

Sources

Publication data from Europe PMC. Clinical trial data from ClinicalTrials.gov, U.S. National Library of Medicine. Public attention from Wikimedia pageview data. Evidence grades from reptides.co. We report counts and dates from these sources and link every record to its origin, we do not summarise findings. Last synced 2026-08-02.